Browsing Category
Health and Safety
Safety is the first pillar of a good life for emergency professionals, rescuers and Fire Fighters. We are operating in a complex and hard environment. Risk prevention and improving working conditions are fundamental for better health and life.
Acute Appendicitis in Multisystem Inflammatory Syndrome in Children With COVID-19: case report from…
Acute appendicitis, a case report from South Africa. The COVID-19 (PIMS-TS) related multisystemic inflammatory syndrome was perhaps the pediatric pathology linked to the coronavirus pandemic that has most questioned researchers around the…
The vaccine against COVID-19, here is the official WHO list: these are the 47 candidates considered…
Vaccine against Covid: there are 47 vaccines that the WHO, the World Health Organization, considers of primary importance and of greater future utility.
HIV, a WHO study: "cabotegravir is highly effective in preventing HIV acquisition in women"
Cabotegravir, a WHO study: the HIV Prevention Trials Network study (HPTN 084) on the safety and efficacy of the long-acting injectable antiretroviral drug cabotegravir (CAB LA), for pre-exposure prophylaxis (PrEP) in HIV-uninfected women,…
COVID-19, antigen tests approved for rapid results by China: results in 20 minutes
China, COVID-19 rapid antigenic tests promising, those announced by the Beijing government. China's top drug regulator has recently approved two antigen tests for COVID-19 that can produce results within 20 minutes, aimed at expediting…
COVID-19 in Chile: Critical hospitalized patients decrease by 82%
COVID-19, Chile is living a very favorable moment, in terms of the fight against coronavirus. It should be emphasized that in the country of the capital Santiago at this time is the height of summer, and the local Red Cross is fighting the…
COVID-19, the USA and the drug of Cuba: Itolizumab adopted in the United States, Mexico, and Brazil
COVID-19, Itolizumab, a monoclonal antibody developed by the Center for Molecular Immunology (CIM), in collaboration with the Indian company Biocon, has received authorization to begin phase III clinical trials in coronavirus patients in…
Correlations between cardiac dysfunction and Covid-19: a Humanitas study to estimate risk factors in…
Cardiac dysfunction and Covid-19, a study of particular relevance. It is the result of a collaboration between the team of clinical and interventional cardiology of Humanitas and the specialists of the Mount Sinai Hospital Group in New York…
COVID-19, researchers focus on nanoantibodies: in Sweden, Karolinska Institutet presents a study on…
COVID-19, are nanoantibodies the solution to stop the spread of coronavirus in the body of affected patients? Researchers at the Karolinska Institutet and the European Molecular Biology Laboratory (EMBL) have published a study on Sybody 23…
Bacterial co-infections in COVID-19 patients: what consequences for the clinical picture and…
Bacterial co-infections in patients with COVID-19: the article "When two for the price of one isn't a bargain: estimating prevalence and microbiology of bacterial co-infections in patients with COVID-19" (PDF at the end), from which a part…
The vaccine for COVID-19? Rich people stuff. High-income countries have already taken 8.8 billion…
The vaccine for COVID-19 (COVAX, as it is defined) is being defined. Many studies, those of major pharmaceutical companies, are now completing phase 3, after which there are the authorization processes by the various regulators. After that,…